openPR Logo
Press release

Urokinase Injection Market Dynamics and Key Factors That Will Drive The Market's Growth, Global Opportunity and Industry Forecast 2029 - Valuates Reports

07-07-2023 06:22 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Valuates Reports

Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
The global Urokinase Injection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Urokinase Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Urokinase Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Urokinase Injection include NDPHARM, Wanhua Biochem, Jiangxi Haoran Bio-Pharma, Jiangsu Aidea Pharmaceutical, Techpool, Microbic Biosystems Inc and LIVZON, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Urokinase Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urokinase Injection.
The Urokinase Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Urokinase Injection market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Urokinase Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Segment by Type
10000-100000IU
100000-1000000IU
Others

Segment by Application
Hospital
Clinic
Others

Get detailed report - https://reports.valuates.com/market-reports/QYRE-Auto-24O9985/global-urokinase-injection

Similar report -

https://reports.valuates.com/market-reports/QYRE-Auto-4E9798/global-urokinase-for-injection

https://reports.valuates.com/market-reports/GENC-Chem-4J29/titanium-dioxide

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.
Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs

Valuates Reports
sales@valuates.com
For U.S. Toll-Free Call 1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp: +91-9945648335
Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Urokinase Injection Market Dynamics and Key Factors That Will Drive The Market's Growth, Global Opportunity and Industry Forecast 2029 - Valuates Reports here

News-ID: 3119245 • Views:

More Releases from Valuates Reports

DUV Lithography Machine Market Share Driven by Semiconductor Advancements and Ch …
DUV Lithography Machine Market Size The global market for DUV Lithography Machine was valued at US$ 15440 million in the year 2024 and is projected to reach a revised size of US$ 22840 million by 2031, growing at a CAGR of 5.8% during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-10P7860/Global_DUV_Lithography_Machine_Market_Insights_and_Forecast_to_2028 The DUV lithography machine market is expanding rapidly as the global semiconductor industry pushes toward higher performance and advanced manufacturing. Market growth is being
FTTx Junction Box Market Share Driven by Fiber Network Expansion and Rising Conn …
FTTx Junction Box Market The global market for FTTx Junction Box was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-30Z12110/Global_FTTx_Junction_Box_Market_Research_Report_2022 The FTTx junction box market is witnessing strong growth as global demand for high-speed internet and reliable digital infrastructure continues to rise. Market trends highlight significant investments in
Virtual Reality (VR) and Augmented Reality (AR) Microdisplay Market Share Driven …
Virtual Reality (VR) and Augmented Reality (AR) Microdisplay Market The global market for Virtual Reality (VR) and Augmented Reality (AR) Microdisplay was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-0L12932/Global_Virtual_Reality_VR_and_Augmented_Reality_AR_Microdisplay_Market_Research_Report_2022 The virtual reality (VR) and augmented reality (AR) microdisplay market is gaining significant momentum as immersive technologies transform
NCA Battery Market Share Driven by Rising Demand for Electric Mobility and Energ …
NCA Battery (Lithium Nickel Cobalt Aluminum Oxide Battery) Market Lithium nickel cobalt aluminum oxide batteries are also called NCA batteries, and are becoming increasingly important in electric powertrains and in grid storage. NCA batteries are not common in the consumer industry, but are promising for the automotive industry. NCA batteries provide a high-energy option with a good lifespan, but they are not as safe as they could be and are quite

All 5 Releases


More Releases for Urokinase

Global Urokinase Market Outlook 2025-2034: Trends, Innovations, And Future Outlo …
The Urokinase Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Urokinase Market Size and Projected Growth Rate? The urokinase market size will grow from $1.7 billion in 2024 to $1.81 billion in 2025 at a CAGR of 6.0%. The growth in the historic
Rising Cardiovascular Disease Burden Drives Urokinase Market Growth Driver: Lead …
What market dynamics are playing a key role in accelerating the growth of the urokinase market? The escalating issue of cardiovascular diseases is projected to augment the expansion of the urokinase market. Cardiovascular diseases (CVDs) encompass a wide array of disorders impacting the heart and blood vessels, including issues like heart attacks, strokes, and hypertension. Higher obesity rates stemming from insufficient physical activity, poor dietary habits, and an aging population are
Urokinase For Injection Market: A Comprehensive Overview
The global Urokinase For Injection market was valued at approximately USD 141.1 million in 3.5% and is projected to reach around USD 199.0 million by 2033, exhibiting a compound annual growth rate (CAGR) of 3.5% during the forecast period. Urokinase For Injection Market Overview Urokinase is a thrombolytic agent used to dissolve blood clots in conditions such as acute myocardial infarction, pulmonary embolism, and deep vein thrombosis. The market's growth
Urokinase Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share
How Big Is the Urokinase Market Expected to Be, and What Will Its Growth Rate Be? In the previous years, the urokinase market has seen robust growth. The market value is expected to increase from $1.7 billion in 2024 to $1.81 billion in 2025 with a Compound Annual Growth Rate (CAGR) of 6.0%. The historic growth trend can be associated with factors such as the rising number of stroke and heart
Urokinase Market Set for Exceptional Growth in the Forecast 2025-2032
Latest Market Overview The global urokinase market is expected to experience significant growth from 2024 to 2032, driven by increasing demand for thrombolytic therapies in various medical applications. As of 2024, the market size is projected to reach USD 2.3 billion and is forecasted to expand at a compound annual growth rate (CAGR) of 7.2% during the forecast period. Urokinase, a protease enzyme primarily used in the treatment of acute myocardial
Scaling for Success: Latest Research on Global Urokinase Market Expansion and Gr …
Global Urokinase Market Overview: Global Urokinase Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Urokinase involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry,